Zyrafete Kuçi
- Genetics top 2%
- Mesenchymal stem cell research 13
- Virus-based gene therapy research 2
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 4
- Urology top 10%
-
- Neuroblastoma Research and Treatments 8
-
- Tissue Engineering and Regenerative Medicine 6
-
- Wound Healing and Treatments 3
-
- Pluripotent Stem Cells Research 2
-
- CAR-T cell therapy research 2
- Co-authors
- Selim KuçiPeter BaderGernot BrucheltThomas KlingebielMaja ReljaZdravko LackovićHalvard BönigRupert Handgretinger
- Cited by
- GeneticsHematologyUrology
- Journals
- Scientific Reports (1 paper)International Journal of Molecular Sciences (1 paper)Journal of Neurochemistry (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Zyrafete Kuçi
25 papers receiving 820 citations
Peers
Comparison fields: 5 of 84
- Genetics 395
- Hematology 93
- Urology 40
- Biomaterials 79
- Cancer Research 86
Countries citing papers authored by Zyrafete Kuçi
This map shows the geographic impact of Zyrafete Kuçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zyrafete Kuçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zyrafete Kuçi more than expected).
Fields of papers citing papers by Zyrafete Kuçi
This network shows the impact of papers produced by Zyrafete Kuçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zyrafete Kuçi. The network helps show where Zyrafete Kuçi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zyrafete Kuçi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2019 | 3 | |
| 4 | 2019 | 57 | |
| 5 | 2019 | 40 | |
| 6 | 2015 | 41 | |
| 7 | 2013 | 38 | |
| 8 | 2012 | 29 | |
| 9 | 2012 | 84 | |
| 10 | 2011 | 26 | |
| 11 | 2011 | 30 | |
| 12 | 2010 | 51 | |
| 13 | 2010 | 142 | |
| 14 | 2009 | 46 | |
| 15 | 2009 | 25 | |
| 16 | 2008 | 22 | |
| 17 | 2006 | 4 | |
| 18 | 2000 | 7 | |
| 19 | 2000 | 1 | |
| 20 | 1990 | 94 |
About Zyrafete Kuçi
Zyrafete Kuçi is a scholar working on Genetics, Neurology and Developmental Neuroscience, having authored 25 papers that have together received 838 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (13 papers), Neuroblastoma Research and Treatments (8 papers), Tissue Engineering and Regenerative Medicine (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Wound Healing and Treatments (3 papers), Pluripotent Stem Cells Research (2 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Genetics (395 citations), Hematology (93 citations) and Urology (40 citations). Zyrafete Kuçi has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Selim Kuçi, Peter Bader, Gernot Bruchelt, Thomas Klingebiel, Maja Relja, Zdravko Lacković, Halvard Bönig, Rupert Handgretinger, Hatixhe Latifi-Pupovci and Hermann Kreyenberg. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.